Log in | Register

Exciting new ECMO technology awaits compelling scientific evidence for widespread use in adults with respiratory failure

Alan H. Morris
Editorial
Volume 38, Issue 2 / February , 2012

Pages 186 - 188

No abstract available.

References

  1. MacLaren G, Combes A, Bartlett RH (2011) Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. doi:10.1007/s00134-011-2439-2
    • View reference on PubMed
  2. Forrest P, Ratchford J, Burns B, Herkes R, Jackson A, Plunkett B, Torzillo P, Nair P, Granger E, Wilson M, Pye R (2011) Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med 37:824–830
  3. Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, Sadique MZ, Sekhon JS, McAuley DF, Firmin RK, Harvey C, Cordingley JJ, Price S, Vuylsteke A, Jenkins DP, Noble DW, Bloomfield R, Walsh TS, Perkins GD, Menon D, Taylor BL, Rowan KM (2011) Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 306(15):1659–1668
  4. Mortensen J (1992) Intravascular oxygenator: a new alternative method for augmenting blood gas transfer in patients with acute respiratory failure. Artif Organs 16:75–82
    • View reference on PubMed
    • View reference on publisher's website
  5. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, Morris AH, Peirce ECI, Thomas AN, Proctor HJ, Drinker PA, Pratt PC, Bagniewski A, Miller RG (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA 242:2193–2196
    • View reference on PubMed
    • View reference on publisher's website
  6. Morris A, Wallace C, Menlove R, Clemmer T, Orme JJ, Weaver L, Dean N, Thomas F, East T, Suchyta M, Beck E, Bombino M, Sittig D, Böhm S, Hoffmann B, Becks H, Pace N, Butler S, Pearl J, Rasmusson B (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for ARDS [erratum 1994;149(3, Pt 1):838, Letters to the editor 1995;151(1):255–256, 1995;151(4):1269–1270, and 1997;156(3):1016–1017]. Am J Respir Crit Care Med 149:295–305
    • View reference on PubMed
  7. MacLaren G (2011) Evidence and experience in extracorporeal membrane oxygenation. Chest 139:965
    • View reference on PubMed
    • View reference on publisher's website
  8. Gattinoni L, Pesenti A, Caspani M, Pelizzola A, Mascheroni D, Marcolin R, Iapichino G, Langer M, Agostoni A, Kolobow T, Melrose D, Damia G (1984) The role of total static lung compliance in the management of severe ARDS unresponsive to conventional treatment. Intensive Care Med 10:121–126
  9. Peek G, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, Killer H, Mugford M, Thalanany M, Tiruvoipati R, Truesdale A, Wilson A (2006) CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res 6:163. doi:10.1186/1472-6963-6-163
  10. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, Hibbert CL, Truesdale A, Clemens F, Cooper N, Firmin RK, Elbourne D (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
    • View reference on PubMed
    • View reference on publisher's website
  11. Morris AH, Hirshberg E, Miller RR, Statler KD, Hite RD (2010) Counterpoint: efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1). Chest 138:778–781
    • View reference on PubMed
    • View reference on publisher's website
  12. Morris AH, Hirshberg E, Miller RR, Statler KD, Hite RD, Hite RD (2010) Rebuttal from Dr. Morris et al. Chest 138:783–784
    • View reference on publisher's website
  13. Morris A (2006) The importance of protocol-directed patient management for research on lung-protective ventilation. In: Dreyfuss D, Saumon G, Hubamyr R (eds) Ventilator-induced lung injury. Taylor & Francis, New York, pp 537–610
  14. Doust J, Mar CD (2004) Why do doctors use treatments that do not work? BMJ 328:474–475
    • View reference on PubMed
    • View reference on publisher's website
  15. FDA (2011) FDA drug safety communication: voluntary market withdrawal of Xigris [drotrecogin alfa (activated)] due to failure to show a survival benefit. Available via http://www.fda.gov/Drugs/DrugSafety/ucm277114.htm. Accessed 25 Oct 2011
  16. Checkley W (2011) Extracorporeal membrane oxygenation as a first-line treatment strategy for ARDS. JAMA 306(15):1703–1704
  17. Bone R (1986) Extracorporeal membrane oxygenation for acute respiratory failure (Editorial). JAMA 256:910
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement